Literature DB >> 28664540

Maintenance diets following rapid weight loss in obstructive sleep apnea: a pilot 1-year clinical trial.

Elizabeth A Cayanan1,2, Nathaniel S Marshall1,2, Camilla M Hoyos1, Craig L Phillips1,3, Yasmina Serinel1, Keith K H Wong1,4, Brendon J Yee1,4, Ronald R Grunstein1,4.   

Abstract

Very low energy diets (VLED) appear to be the most efficacious dietary-based obesity reduction treatments in obstructive sleep apnea (OSA); however, effective weight loss maintenance strategies remain untested in this condition. Our study aimed to assess the feasibility, tolerability and efficacy of two common maintenance diets during a 10-month follow-up period after rapid weight loss using a 2-month VLED. In this two-arm, single-centre, open-label pilot trial, obese adult OSA patients received a 2-month VLED before being allocated to either the Australian Guide to Healthy Eating diet (AGHE) or a low glycaemic index high-protein diet (LGHP). Outcomes were measured at 0, 2 and 12 months. We recruited 44 patients [113.1 ± 19.5 kg, body mass index (BMI): 37.2 ± 5.6 kg m-2 , 49.3 ± 9.2 years, 12 females]. Twenty-four patients were on continuous positive airway pressure (CPAP) or mandibular advancement splint (MAS) therapy for OSA. Forty-two patients completed the VLED. The primary outcome of waist circumference was reduced by 10.6 cm at 2 months [95% confidence interval (CI): 9.2-12.1], and patients lost 12.9 kg in total weight (95% CI: 11.2-14.6). There were small but statistically significant regains in waist circumference between 2 and 12 months [AGHE = 3.5 cm (1.3-5.6) and LGHP = 2.8 cm (0.6-5.0]. Other outcomes followed a similar pattern of change. After weight loss with a 2-month VLED in obese patients with OSA, a structured weight loss maintenance programme incorporating commonly used diets was feasible, tolerable and efficacious for 10 months. This programme may be deployed easily within sleep clinics; however, future research should first test its translation within general clinical practice.
© 2017 European Sleep Research Society.

Entities:  

Keywords:  Very Low Calorie Diet; cardiovascular; metabolic syndrome quality of life; weight regain

Mesh:

Year:  2017        PMID: 28664540     DOI: 10.1111/jsr.12572

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  5 in total

1.  Parsing the craniofacial phenotype: effect of weight change in an obstructive sleep apnoea population.

Authors:  Kate Sutherland; Julia L Chapman; Elizabeth A Cayanan; Aimee B Lowth; Keith K H Wong; Brendon J Yee; Ronald R Grunstein; Nathaniel S Marshall; Peter A Cistulli
Journal:  Sleep Breath       Date:  2019-03-29       Impact factor: 2.816

2.  Effectiveness of an intensive weight-loss program for severe OSA in patients undergoing CPAP treatment: a randomized controlled trial.

Authors:  Carla López-Padrós; Neus Salord; Carolina Alves; Núria Vilarrasa; Merce Gasa; Rosa Planas; Monica Montsserrat; M Nuria Virgili; Carmen Rodríguez; Sandra Pérez-Ramos; Esther López-Cadena; M Inmaculata Ramos; Jordi Dorca; Carmen Monasterio
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

3.  A moment on the lips, a lifetime on the mask: weight-loss programs and sleep apnea.

Authors:  Henry W Ainge-Allen; Brendon J Yee
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 4.  From CPAP to tailored therapy for obstructive sleep Apnoea.

Authors:  Kate Sutherland; Kristina Kairaitis; Brendon J Yee; Peter A Cistulli
Journal:  Multidiscip Respir Med       Date:  2018-12-03

5.  Predictors of weight loss in obese patients with obstructive sleep apnea.

Authors:  Thomas J Altree; Delwyn J Bartlett; Nathaniel S Marshall; Camilla M Hoyos; Craig L Phillips; Callum Birks; Aran Kanagaratnam; Anna Mullins; Yasmina Serinel; Keith K H Wong; Brendon J Yee; Ronald R Grunstein; Elizabeth A Cayanan
Journal:  Sleep Breath       Date:  2021-08-06       Impact factor: 2.816

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.